A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain

Tools4Patient110 enrolled

Overview

Patients having completed former trials T1001-01 or T1001-02 will undergo one blood sampling for genotyping purposes. In addition they will compete the personality questionnaires they had completed in the former trial.

Study Type

INTERVENTIONAL

Allocation

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

110

Conditions

Peripheral Neuropathy Osteoarthritis

Interventions

Blood sampling for genotypingGENETIC

Venous punction of maximum 10 millilitres

Personality Questionnaires completionOTHER

Completion of the following questionnaires: Multidimensional Personality Questionnaire (MPSQ), Interpersonal Reactivity Index (IRI) and Behavioral inhibition system/ Behavioral activation systems (BISBAS) questionnaires

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * have completed T1001-01 or T1001-02 study (Visit 5 completed) * are men or women of at least 18 years of age * have given written informed consent approved by the relevant Ethics Committee governing the study sites Exclusion Criteria: * have any close relationship with the Investigators or the Sponsor * are under legal protection, according to the national law

Locations (4)

ATC SA

Liège, Belgium

CIC Clermont-Ferrand CHU G. Montpied

Clermont-Ferrand, France

Eurofins Optimed

Gières, France

Institut Curie

Paris, France

Outcomes

Primary Outcomes

Number of participants with Single Nucleotide Polymorphisms (SNPs) variation of catechol-O-methyltransferase

SNPs will be analyzed with Sanger based genotyping or equivalent method